Statistics
Publications
25
Citations
1.2K
H-Index
18
Active since
2006
Haifeng Luo is an author at First Affiliated Hospital of Dalian Medical University specializing in oncology, medicine, and molecular oncology.
Publications per year
2006–2024
25
25
Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
Hongjiang Wang, Guang Tan, Lei Dong et al. · PLoS ONE · 2012 · 274 citations · Full text
USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma
Zhen Ning, Xin Guo, Xiaolong Liu et al. · Nature Communications · 2022 · 178 citations · Full text
Luteolin ameliorates LPS-induced acute liver injury by inhibiting TXNIP-NLRP3 inflammasome in mice
Xiaohui Wang, Lu Wang, Renchao Dong et al. · Phytomedicine · 2021 · 105 citations
USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma
Chang Lu, Zhen Ning, Aman Wang et al. · Cancer Letters · 2018 · 97 citations
Medicine, Cancer Biology, Oncology +16
Zhikun Lin, Ruiping He, Haifeng Luo et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 52 citations · Full text
Medicine, Cell Biology, Oncology +17
1–5 of 25